Try HoloMonitor from a distance —
book your free live cell demo
!
Home
/
Investor Relati…
/
News
About
Our Story
To understand and cure the diseases that still plague humanity, medical science needs new tools.
Our Story
Background
Management and Board
Career
Partnerships
National Institute on Aging
Northeastern University
Huntsman Cancer Institute
UCSF
Gladstone Institutes
Lund University Cancer Centre
Malmö University
Uppsala University
Products
HoloMonitor
The HoloMonitor cell culture microscope non-invasively analyses cellular response and dynamic behavior in an …
HoloMonitor
Cell Imaging System
System Components
App Suite Cell Imaging Software
HoloLids
Technology
Gentle Live Cell Imaging
Quantitative Phase Imaging
Holographic Microscopy
Time-lapse Imaging Cytometry
Applications
Overview
Explore our range of live cell imaging applications and assays, circumventing the drawbacks of traditional …
Overview
Single-Cell Analysis
Cell QC
Cell Counter
Cell Proliferation
Cell Migration
Cell Motility and Migration
Cell Motility
Wound Healing
Dose Response
Cell Morphology
Cell Tracking
Publications
News
News and press releases.
News
Peer Reviewed Publications
Conference Papers and Posters
Doctoral Thesis
Resources
Webinars
We are happy to invite you to our series of live cell imaging webinars! Welcome to attend live, or view on demand …
Cell Videos & Tutorials
Brochures & Flyers
Application Notes
Manuals & Protocols
Webinars
Users
Blog
The Cell Cycle
Investor Relations
CEO Commentaries
CEO Peter Egelberg's blog, commenting PHI and medical science in general.
Introduktion
Bolagspresentation
Videopresentationer
CEO Commentaries
IR Contact
Stock Information
Reports & Documents
Investor Calendar
News
Contact
Book a Live Cell Imaging Demo
Book your live cell imaging demo of the incubator-based HoloMonitor cell culture microscope.
Contact PHI
Distributors
Contact IR
Book a Live Cell Imaging Demo
Shop
Webshop
Shop HoloMonitor products, applications and download the App Suite software.
Webshop
Cart
Checkout
My Account
Terms and Conditions
News
In English
April 19, 2021
Sahlgrenska acquires second HoloMonitor System
After an initial purchase by Sahlgrenska University Hospital, Sahlgrenska Center for Cancer Research acquires a second HoloMonitor system.
April 7, 2021
BioSpherix Partnership Yields HoloMonitor Customer in Regenerative Medicine
Recently, the EU-funded Centre for Innovative Medicine in Vilnius purchased its first HoloMonitor analyzer for use in the center's incubator system from BioSpherix.
March 25, 2021
Harvard Researchers Purchase HoloMonitor
Partners HealthCare International in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.
March 16, 2021
Interim Report 3 (2020-11-01 – 2021-01-31)
The second wave of the pandemic restricted sales during the 3rd quarter. However, the situation has improved significantly since late January.
January 21, 2021
PHI secure working capital until 2023
PHI has received a second loan commitment of 20 MSEK. In total, the company has received loan commitments of 35 MSEK that are expected to secure the company's working capital until 2023.
December 14, 2020
Interim Report 2 (2020-08-01 – 2020-10-31)
The relaxed COVID-19 restrictions during the 2nd quarter led to a noticeable increase in sales.
1
2
…
13
In Swedish
April 19, 2021
Sahlgrenska köper ett andra HoloMonitorsystem
Sahlgrenska Centrum för Cancerforskning har köpt ett andra HoloMonitorsystem till Sahlgrenska, efter att Sahlgrenska Universitetssjukhuset tidigare köpt ett system.
April 7, 2021
Samarbetet med BioSpherix ger HoloMonitor-kund inom regenerativ medicin
Nyligen köpte det EU-finansierade Centre for Innovative Medicine i Vilnius sin första HoloMonitor-analysator för att användas i centrets inkubatorsystem från BioSpherix.
March 25, 2021
Harvardforskare köper HoloMonitor
Partners HealthCare International i Boston, Massachusetts, beställde nyligen sin första och fullt utrustade HoloMonitor-enhet.
March 16, 2021
Delårsrapport 3 (2020-11-01 – 2021-01-31)
Pandemins andra våg begränsade försäljningsmöjligheterna under 3:e kvartalet. Situationen har dock förbättrats avsevärt sedan slutet av januari.
September 30, 2020
Årsredovisning 2019/20
Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avger härmed årsredovisning för räkenskapsåret 1 maj 2019 – 30 april 2020.
October 15, 2019
Kommuniké från årsstämma i Phase Holographic Imaging AB (publ)
Phase Holographic Imaging AB (publ) avhöll den 15 oktober 2019 sin årsstämma.
1
2
3
Latest CEO Commentaries
August 26, 2020
Probably, the fastest website in the world
The page you now are reading probably appeared faster on your screen than any other web page you have read.
March 31, 2020
Bridging Corona
As the dust from the stampede of bewildered politicians and overconfident billionaires settles, we begin to discern the new world shaped by the COVID-19 pandemic.
March 2, 2020
Joining forces with Huntsman
PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer. Using PHI's HoloMonitor technology, the researchers at Huntsman aim to develop methods quantifying the phenomena known as epithelial–mesenchymal transition (EMT).
View all commentaries